ACASTI PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.85 USD | +2.52% |
|
-1.72% | -1.38% |
| 02-12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
| 02-07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 25/04/2024 | 26/04/2024 | 29/04/2024 | 30/04/2024 | 01/05/2024 | |
|---|---|---|---|---|---|
| Last | 2.9285 $ | 2.9 $ | 2.68 $ | 2.78 $ | 2.85 $ |
| Volume | 2 583 | 3 831 | 6 916 | 10 392 | 4 500 |
| Change | +0.98% | -0.97% | -7.59% | +3.73% | +2.52% |
| Opening | 2.86 | 2.80 | 2.84 | 2.70 | 2.77 |
| High | 2.93 | 3.13 | 2.84 | 3.05 | 2.93 |
| Low | 2.86 | 2.77 | 2.66 | 2.65 | 2.7 |
Performance
| 1 day | +2.52% | ||
| 1 week | -1.72% | ||
| Current month | +2.52% | ||
| 1 month | -17.39% | ||
| 3 months | +16.33% | ||
| 6 months | +18.26% | ||
| Current year | -1.38% | ||
| 1 year | +4.03% | ||
| 3 years | -87.11% | ||
| 5 years | -93.06% | ||
| 10 years | -99.41% |
Volumes
marketsDaily volume
4 500
Estimated daily volume
4 500
Avg. Volume 20 sessions
12 178
Daily volume ratio
0.37
Avg. Volume 20 sessions USD
34 708.52
Record volume 1
11 730 010
Record volume 2
7 917 576
Record volume 3
4 505 844
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
26 130 343
Net sales (CAD)
0
Net sales (USD)
0
Number of employees
32
Sales / Employee (CAD)
0
Sales / Employee (USD)
0
Free-Float
83.98 %
Free-Float capitalization (USD)
21 944 058
Average Daily Capital Traded
0.1%
Highs and lows
1 week
2.65
3.13
1 month
2.653.50
Current year
1.983.59
1 year
1.723.84
3 years
1.7232.64
5 years
1.72147.84
10 years
1.72585.60
Indicators
Moving average 5 days
2.84
Moving average 20 days
3.18
Moving average 50 days
3.30
Moving average 100 days
2.89
Price spread / (MMA5)
-0.44%
Price spread / (MMA20)
+11.56%
Price spread / (MMA50)
+15.84%
Price spread / (MMA100)
+1.52%
STIM
RSI 9 days
12.68
RSI 14 days
18.63
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.52% | -1.72% | -1.38% | +4.03% | 26.13M | ||
| -0.56% | +6.08% | +33.25% | +91.41% | 704B | ||
| -0.54% | +0.72% | +28.59% | +58.77% | 577B | ||
| +4.56% | +1.78% | -3.55% | -7.59% | 348B | ||
| -0.31% | +1.43% | +18.16% | +10.73% | 327B | ||
| -0.57% | -3.62% | +4.36% | +5.21% | 288B | ||
| +0.90% | +8.00% | +14.81% | +3.36% | 234B | ||
| +0.20% | +1.93% | +4.93% | -2.28% | 198B | ||
| -0.27% | -2.30% | -9.78% | -21.31% | 194B | ||
| +1.26% | +1.61% | -3.69% | +16.12% | 147B | ||
| +6.09% | +3.46% | -5.59% | -30.68% | 145B | ||
| +1.35% | +5.57% | +3.70% | -6.92% | 124B | ||
| +0.61% | -9.52% | -13.84% | -35.37% | 89.07B | ||
| +1.91% | +3.27% | +17.57% | +17.17% | 85.62B | ||
| +0.48% | -2.34% | -19.13% | -19.54% | 81.3B | ||
| -0.54% | +14.41% | +37.78% | +15.85% | 65.32B | ||
| Average | +1.11% | +0.36% | +6.64% | +6.18% | ||
| Weighted average by Cap. | +0.66% | +0.95% | +13.49% | +25.39% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
abda2f7233bd1d8eddc68a1918a2b0.nWDqcrDf5ASSOWVebvZqFwm9g4iUEZ465Sm0f-thEx0.7AnTP9KIvW_NXhYdJqReYGeMyNKmTtVKt3bFKr8KaU_WMIsk1o2pXfFDVQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 20:54:26 | 2.85 | 100 | 3,828 |
| 20:54:26 | 2.85 | 100 | 3,728 |
| 20:31:25 | 2.899 | 1,000 | 3,628 |
| 20:21:07 | 2.865 | 511 | 2,628 |
| 20:13:11 | 2.817 | 104 | 2,117 |
| 18:58:53 | 2.728 | 184 | 2,013 |
| 18:58:53 | 2.8 | 100 | 1,829 |
| 16:25:26 | 2.83 | 498 | 1,729 |
| 16:15:04 | 2.7 | 250 | 1,231 |
| 15:58:47 | 2.86 | 166 | 981 |
Monthly variations
Annual change
| 2024 | -3.81% | ||
| 2023 | -3.86% | ||
| 2022 | -60.24% | ||
| 2021 | -51.54% | ||
| 2020 | -86.73% | ||
| 2019 | +194.51% | ||
| 2018 | -11.76% | ||
| 2017 | -24.58% | ||
| 2016 | -50.98% | ||
| 2015 | -49.00% | ||
| 2014 | -60.00% | ||
| 2013 | -41.91% | ||
| 2012 | +62.29% | ||
| 2011 | +8.08% |
- Stock Market
- Equities
- ACST Stock
- Quotes Acasti Pharma Inc.
